BACKGROUND: Gastroesophageal reflux disease (GERD) has been increasingly recognized in patients with morbid obesity. A recent global evidence-based consensus on GERD has been proposed, but its performance in patients with morbid obesity is unknown. The aim of this study was to assess the performance of the Montreal Consensus in the diagnosis of GERD in morbidly obese patients. METHODS: Seventy-five consecutive morbidly obese patients underwent GERD symptoms assessment, upper gastrointestinal endoscopy, and ambulatory esophageal pH monitoring "off PPI". The performance of the Montreal Consensus was determined by comparing two diagnostic algorithms: 1. a gold standard approach in which any GERD symptom and findings from both endoscopy and pH monitoring were taken into account, and 2. the approach with the Montreal Consensus, in which troublesome GERD symptoms and endoscopic findings were considered. RESULTS: GERD was found present in 57 patients by applying the gold standard approach. The Montreal Consensus identified 41 of these patients, whereas the remaining 34 patients were classified as "no GERD". Of these, 16 (47%) showed reflux esophagitis and/or abnormal pH-metry. The Montreal Consensus had an accuracy of 78.7%, sensitivity of 72% (95% CI 59-82%), specificity of 100% (95% CI 82-100%) and negative predictive value of 47% (95% CI 37-57%). CONCLUSIONS: In morbidly obese patients, the approach with the Montreal Consensus has high specificity and suboptimal sensitivity in the diagnosis of GERD. Its intermediate negative predictive value suggests that complementary investigation might be routine in these patients, particularly in those who do not present with troublesome GERD symptoms.
BACKGROUND:Gastroesophageal reflux disease (GERD) has been increasingly recognized in patients with morbid obesity. A recent global evidence-based consensus on GERD has been proposed, but its performance in patients with morbid obesity is unknown. The aim of this study was to assess the performance of the Montreal Consensus in the diagnosis of GERD in morbidly obesepatients. METHODS: Seventy-five consecutive morbidly obesepatients underwent GERD symptoms assessment, upper gastrointestinal endoscopy, and ambulatory esophageal pH monitoring "off PPI". The performance of the Montreal Consensus was determined by comparing two diagnostic algorithms: 1. a gold standard approach in which any GERD symptom and findings from both endoscopy and pH monitoring were taken into account, and 2. the approach with the Montreal Consensus, in which troublesome GERD symptoms and endoscopic findings were considered. RESULTS: GERD was found present in 57 patients by applying the gold standard approach. The Montreal Consensus identified 41 of these patients, whereas the remaining 34 patients were classified as "no GERD". Of these, 16 (47%) showed reflux esophagitis and/or abnormal pH-metry. The Montreal Consensus had an accuracy of 78.7%, sensitivity of 72% (95% CI 59-82%), specificity of 100% (95% CI 82-100%) and negative predictive value of 47% (95% CI 37-57%). CONCLUSIONS: In morbidly obesepatients, the approach with the Montreal Consensus has high specificity and suboptimal sensitivity in the diagnosis of GERD. Its intermediate negative predictive value suggests that complementary investigation might be routine in these patients, particularly in those who do not present with troublesome GERD symptoms.
Authors: Fernando Fornari; Antônio Carlos Gruber; Antônio de Barros Lopes; Dileta Cecchetti; Sérgio Gabriel Silva de Barros Journal: Arq Gastroenterol Date: 2005-03-29
Authors: Douglas A Corley; Ai Kubo; Theodore R Levin; Gladys Block; Laurel Habel; Wei Zhao; Pat Leighton; Charles Quesenberry; Greg J Rumore; Patricia A Buffler Journal: Gastroenterology Date: 2007-04-25 Impact factor: 22.682
Authors: Daniel Navarini; Carlos Augusto S Madalosso; Alexandre P Tognon; Fernando Fornari; Fábio R Barão; Richard R Gurski Journal: Obes Surg Date: 2020-04 Impact factor: 4.129
Authors: Fernando Fornari; Richard Ricachenevsky Gurski; Daniel Navarini; Victor Thiesen; Luis Henrique Barbosa Mestriner; Carlos Augusto Scussel Madalosso Journal: Obes Surg Date: 2009-09-12 Impact factor: 4.129